Abstract
Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.
Original language | English (US) |
---|---|
Pages (from-to) | 495-512 |
Number of pages | 18 |
Journal | Gastrointestinal Endoscopy Clinics of North America |
Volume | 18 |
Issue number | 3 |
DOIs | |
State | Published - Jul 2008 |
ASJC Scopus subject areas
- Gastroenterology